'Smart glasses' can improve gait of Parkinson's patients

A new app for intelligent glasses, such as Google Glass, will soon make it possible to improve the gait of patients suffering from Parkinson's disease and to decrease their risk of falling. Researchers at the University of Twente's MIRA Institute have received a grant from the NutsOhra fund for the development of the app.

The gait of Parkinson's is often disturbed: sometimes this presents as a shuffling movement with the patient taking , or it may result in the patient constantly looking for additional support. Gait disturbance also increases the chance of a fall, despite the progress made in terms of medication. Researchers have established that the of patients improves when they regularly see or hear a pattern. Examples might include stripes on the floor, or the regular ticking of a metronome.

The researchers, working under the leadership of Prof. Richard van Wezel, who is professor of Neurophysiology at the UT and is also attached to the Donders Institute in Nijmegen, are now looking at exploring the possibility of using the intelligent glasses, such as Google Glass, that are now coming on to the consumer market.

Intelligent glasses would be able to provide patients with the regular visual or audible patterns required. These patterns may take the form of moving stripes or shapes which the patient sees through the glasses, flashing shapes, or music with varying tempos. The latest intelligent glasses already have inbuilt cameras and accelerometers. By using these, it will be possible to determine which approach works best for each individual patient.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Parkinson's disease reverted at a experimental stage

Dec 19, 2014

Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide. The experiments ...

EU team launches clinical trial of Parkinson's vaccine

Dec 09, 2014

Today the EU-consortium SYMPATH starts recruitment for a Phase I study of a Parkinson's vaccine candidate called AFFITOPE PD03A. This vaccine is one out of a designated pool of promising vaccine candidates based on AFFiRiS' ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.